Irvine, CA, United States of America

Daryl Chau

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daryl Chau: Innovator in AI-Driven Healthcare Solutions

Introduction

Daryl Chau is a notable inventor based in Irvine, CA, who has made significant contributions to the field of healthcare technology. His innovative work focuses on integrating artificial intelligence to monitor and remediate withdrawal symptoms in patients, particularly in neonates and adults.

Latest Patents

Daryl Chau holds a patent for an "Integrated artificial intelligence based system for monitoring and remediating withdrawal symptoms." This system is designed to identify Neonatal Abstinence Syndrome (NAS) in infants and monitor withdrawal and relapse symptoms in adults. The technology utilizes biosensor and behavioral information collected from wearable devices, high precision cameras, and multi-pitch microphones. The AI module within the system predicts treatment needs and recommends appropriate actions based on the data collected.

Career Highlights

Daryl Chau is currently associated with Rekovar, Inc., where he applies his expertise in developing advanced healthcare solutions. His work is pivotal in enhancing patient care through technology, particularly for vulnerable populations such as infants experiencing NAS.

Collaborations

Daryl collaborates with talented professionals in his field, including Shiva Sharareh and Abel Jimenez. Their combined efforts contribute to the innovative projects at Rekovar, Inc., pushing the boundaries of healthcare technology.

Conclusion

Daryl Chau's contributions to the integration of artificial intelligence in healthcare demonstrate his commitment to improving patient outcomes. His innovative patent reflects a significant advancement in monitoring and treating withdrawal symptoms, showcasing the potential of technology in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…